Data / Form D filings / Turing Pharmaceuticals AG
Turing Pharmaceuticals AG: Form D filings
Turing Pharmaceuticals AG, a pharmaceuticals company in Baar, Switzerland, filed 2 Form D notices with the SEC in 2015. The latest, on August 19, 2015, reports $90.3 million sold of an offering with no set size to 43 investors.
Find out what Turing Pharmaceuticals AG does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- Haldenstrasse 5, Baar, Switzerland, CH-63
- Phone
- (646) 356-5577
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Switzerland
- Year incorporated
- 2014
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1650139
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 19, 2015 | Amendment | Indefinite | $90,277,685 | Indefinite | 43 | Jul 23, 2015 | sec.gov |
| Aug 6, 2015 | New notice | $62,704,170 | $62,704,170 | $0 | 34 | Jul 23, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ron Tilles | Director | |
| Alan Geller | Director | |
| Walter Blum | Director | |
| Martin Shkreli | Executive Officer, Director | |
| Michael Harrison | Executive Officer |
Every Form D from the week of Aug 17, 2015 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Turing Pharmaceuticals AG reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.